Bright Minds Biosciences Inc.
DRUG
CNSX
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/14/2025
-
MarketBeat
3/15/2026
-
MarketBeat
3/13/2026
-
Tickeron - Stocks
3/11/2026
-
Tickeron - Stocks
3/5/2026
-
Ticker Report
3/5/2026
-
Tickeron - Stocks
3/5/2026
-
Tickeron - Stocks
3/4/2026
-
MarketBeat
3/4/2026
-
Tickeron - Stocks
3/3/2026
-
Tickeron - Technical Analysis
3/3/2026
-
MarketBeat
3/3/2026
-
Ticker Report
2/28/2026
-
Tickeron - Stocks
2/28/2026
-
MarketBeat
2/25/2026
-
Globe Newswire
2/20/2026
-
MarketBeat
2/20/2026
-
Tickeron - Stocks
2/20/2026
-
Tickeron - Stocks
2/20/2026
-
Ticker Report
Bright Minds Biosciences (DRUG, $80.3) price exceeded its 50-day Moving Average on February 18, 2026
2/19/2026
-
Tickeron - Technical Analysis
2/19/2026
-
Insider Monkey
2/18/2026
-
Tickeron - Technical Analysis
2/18/2026
-
Tickeron - Technical Analysis
2/18/2026
-
Tickeron - Technical Analysis
2/18/2026
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
647 865 8622
Address
19 Vestry Street
New York, NY 10013
New York, NY 10013
Country
Year Founded
Business Description
Sector
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes...
more